Yağmur Kiraz

5PUBLICATIONS
12CO-AUTHORS
Molecular targetsHaematological tumoursBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 25, 2026
Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells.

|Jan 05, 2026
Lineage-specific transcriptomic signatures and therapeutic target discovery in myeloid and lymphoid leukemias.

Başak Özay, Onur Ateş, Yağmur Kiraz

|Jul 05, 2025
Determination of survival associated genetic biomarkers to discover novel therapeutic targets for acute myeloid leukaemia.

Cansu Ergun, Yağmur Kiraz, Gizem Ayna Duran

|Jul 02, 2024
In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment.

Ezgi Yağmur Tükel, Onur Ateş, Yağmur Kiraz

|Dec 14, 2019
Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia

Duygu Koca, Nurcan Hastar, Selin Engür

Pageof 1

Frequent Collaborators

1 joint publications

Duygu Koca

1 joint publications

Nurcan Hastar

1 joint publications

Gizem Tuğçe Ulu

1 joint publications

Demet Çekdemir